tiprankstipranks
Trending News
More News >
Novonesis (DE:NZM)
FRANKFURT:NZM
Germany Market
Advertisement

Novonesis (NZM) Earnings Dates, Call Summary & Reports

Compare
5 Followers

Earnings Data

Report Date
Feb 25, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.76
Last Year’s EPS
0.58
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong organic growth, particularly in emerging markets, and a robust pipeline of innovative products. However, challenges such as currency headwinds, the impact of exiting certain countries, and declines in the Beverage segment were noted.
Company Guidance
During the Novonesis conference call for the first nine months of 2025, the company provided updated guidance and performance metrics. The firm delivered an organic sales growth of 8%, with the third quarter achieving a 6% increase, primarily driven by volume, as pricing contributed around 1%. Emerging markets showed robust growth at 12%, while developed markets grew by 6%. The adjusted EBITDA margin improved to 37.3%, up by 1.3 percentage points from the previous year, despite significant currency headwinds. For the entire year, Novonesis revised its organic sales growth expectation to 7% to 8%, anticipating mid-single-digit growth in the fourth quarter. The adjusted EBITDA margin is projected to be at the lower end of the 37% to 38% range. The company's strategic investments in emerging markets and its recent acquisition of the Feed Enzyme Alliance were highlighted as significant growth drivers.
Strong Organic Sales Growth
Novonesis delivered organic sales growth of 8% in the first 9 months of 2025, with the third quarter growing by 6%. Growth was broad-based and mainly volume-driven.
Emerging Markets Performance
Emerging markets experienced a 12% growth, driven by increased local presence and tailored solutions, significantly outgrowing developed markets.
Adjusted EBITDA Margin Improvement
The adjusted EBITDA margin for the first 9 months was 37.3%, an increase of 1.3 percentage points compared to last year, despite significant currency headwinds.
Innovative Product Launches
Novonesis launched 19 new Biosolutions in 2025, including high-performance solutions for various industries, contributing significantly to growth.
Cash Flow and Earnings Growth
Free cash flow before acquisitions increased by 16% to EUR 668 million, and diluted adjusted earnings per share increased by 20%.

Novonesis (DE:NZM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:NZM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
0.76 / -
0.582
Nov 06, 2025
2025 (Q3)
0.41 / 0.41
0.32725.46% (+0.08)
Aug 21, 2025
2025 (Q2)
0.58 / 0.36
0.598-39.42% (-0.24)
May 08, 2025
2025 (Q1)
0.38 / 0.41
0.465-11.57% (-0.05)
Feb 26, 2025
2024 (Q4)
0.47 / 0.58
0.31684.11% (+0.27)
Nov 07, 2024
2024 (Q3)
0.50 / -
0.413
Aug 27, 2024
2024 (Q2)
0.56 / 0.60
0.278114.95% (+0.32)
May 03, 2024
2024 (Q1)
0.51 / 0.78
0.362114.83% (+0.42)
Feb 01, 2024
2023 (Q4)
0.40 / 0.32
0.402-21.34% (-0.09)
Oct 26, 2023
2023 (Q3)
0.36 / 0.41
0.471-12.34% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:NZM Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 21, 2025
€54.83€52.34-4.54%
May 08, 2025
€56.33€56.83+0.88%
Feb 26, 2025
€52.01€52.50+0.95%
Nov 07, 2024
€55.97€53.00-5.31%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Novonesis (DE:NZM) report earnings?
Novonesis (DE:NZM) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
    What is Novonesis (DE:NZM) earnings time?
    Novonesis (DE:NZM) earnings time is at Feb 25, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Novonesis stock?
          The P/E ratio of Novonesis is N/A.
            What is DE:NZM EPS forecast?
            DE:NZM EPS forecast for the fiscal quarter 2025 (Q4) is 0.76.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis